What ACON Laboratories does

ACON Laboratories, Inc. is a privately held medical device and in-vitro diagnostics manufacturer founded in 1996 and headquartered in San Diego, California. The company develops lateral flow chromatographic immunoassay-based rapid diagnostic tests, point-of-care analyzers, and blood glucose monitoring systems sold across multiple brands, including Flowflex (rapid antigen tests, America's #1 home test kit by units sold per Circana), On Call (blood glucose meter systems), Mission (point-of-care testing), HealthyMe (UTI strips, described as the leading U.S. UTI manufacturer), Distinct (pregnancy tests), Foresight (allergen testing), Promotor (molecular diagnostics), and CentriVet (animal health). Its core technology platform is lateral flow immunoassay, with reported performance metrics of 100% combined sensitivity for the SARS-CoV-2 IgG/IgM Rapid Test and >99% accuracy for the Distinct Early Detection Pregnancy Test.

ACON serves a hybrid customer base spanning institutional healthcare providers (hospitals, clinical laboratories, physician offices, blood banks, pharmacies, and veterinary clinics) and end consumers purchasing OTC products through major U.S. retailers, authorized distributor networks, e-commerce platforms, and government health systems including the UK NHS. The company operates a multi-region manufacturing footprint comprising a 97,000 sq ft FDA-registered San Diego facility, an ISO13485-certified and FDA-registered Hangzhou, China facility, and a Tijuana, Mexico contract manufacturing plant, with products distributed in over 130 countries. Revenue is generated through hardware sales of diagnostic tests and consumables (the dominant stream), OEM contract manufacturing services for third-party diagnostic products, and On Call Care Alliance subscription-based communication services for healthcare providers and consumers.

Strategically, ACON has leveraged first-mover FDA regulatory positioning—securing the first 510(k) clearance for an OTC COVID-19 rapid antigen test in November 2023 and the first 510(k) clearance for an at-home 4-in-1 respiratory panel (RSV, Flu A/B, COVID-19) in October 2025—to expand its addressable market beyond pandemic-era testing into broader multi-pathogen respiratory diagnostics and adjacent testing categories. The company is privately held with no disclosed venture capital or private equity investment and is led by founder and President/CTO Jinn-nan Lin.

Name

ACON Laboratories

Legal name

ACON Laboratories, Inc.

Website

https://aconlabs.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ACON Laboratories is a privately held San Diego-based in-vitro diagnostics manufacturer founded in 1996, producing FDA-cleared lateral flow rapid tests (notably the #1 U.S. home test kit, Flowflex), point-of-care analyzers, and blood glucose monitoring systems sold in 130+ countries to healthcare providers, major retailers, and government health systems.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics / Medical Diagnostic Devices

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)

akta.pro secondary industries

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK), Autoimmune & Allergy Diagnostics (HLAAALAK)

Keywords

• Rapid diagnostic tests
• Lateral flow immunoassays
• Point-of-care testing
• Blood glucose monitoring
• Molecular diagnostics

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Medical Devices and Tests: Sale of rapid diagnostic tests, blood glucose meters, point-of-care testing analyzers, and related consumables to healthcare facilities and consumers
2. Contract Manufacturing (OEM): OEM contract manufacturing services for third-party diagnostic products
3. On Call Care Alliance Services: Healthcare provider and consumer communication services for ACON product test results

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

ACON Laboratories manufactures and sells FDA-cleared rapid diagnostic tests, point-of-care testing analyzers, blood glucose monitoring systems, lateral flow immunoassays, and molecular diagnostic kits. Its products span infectious disease (COVID-19, RSV, influenza), pregnancy, urinalysis, diabetes management, allergy screening, and veterinary diagnostics, sold in over 130 countries through major retailers, authorized distributors, and e-commerce platforms.

Differentiator

Problem solved

Functional benefit

Brands

• On Call: Blood glucose meter systems for diabetes management, including Express, Express II, Express Mobile, Express Voice, Extra, Extra Mobile, and Pro families.
• Mission
• HealthyMe
• Flowflex
• Distinct
• Foresight
• Promotor
• CentriVet

Products and services

• Flowflex COVID-19 Antigen Home Test Single-test OTC rapid antigen test for SARS-CoV-2 detection using nasal swab specimens with 15-minute results, intended for at-home non-prescription use by consumers. America's #1 home test kit by units sold (Circana).
• Flowflex Plus COVID-19 + Flu A/B Home Test Over-the-counter at-home rapid antigen test that simultaneously detects and differentiates COVID-19, influenza A, and influenza B from a single nasal swab, designed for non-prescription home use.
• Flowflex Plus 4-in-1 RSV + Flu A/B + COVID Home Test First FDA-cleared at-home 4-in-1 rapid antigen test detecting RSV, influenza A/B, and COVID-19 from a single nasal swab, for use in adults and children 6 months and older.
• SARS-CoV-2 IgG/IgM Rapid Test Lateral flow immunoassay for the qualitative detection and differentiation of IgG and IgM antibodies to SARS-CoV-2, intended for professional use by authorized laboratories.
• Distinct Early Detection Pregnancy Test FDA-cleared OTC pregnancy test detecting hCG levels as early as 6 days before a missed period with >99% accuracy, sold to consumers through major retailers.
• On Call MultiPro System Multi-assay point-of-care analyzer for HbA1c, ACR, and CRP testing with LIS connectivity, designed for use in physician offices, clinics, and hospitals in Europe and Latin America.
• On Call Blood Glucose Monitoring Systems Branded family of blood glucose meters and strips (Express, Express II, Express Voice, Express Mobile, Extra, Extra Mobile, Sure, Sure Sync, Pro) for diabetes management, with both professional and consumer variants and Bluetooth-enabled data integration.
• Mission Point-of-Care Testing Products Point-of-care testing portfolio under the Mission brand including urine reagent test strips, urine analyzers, handheld devices for cholesterol, coagulation, hemoglobin, and lipid panel monitoring systems sold to clinical labs and physician offices.
• HealthyMe Urinary Tract Infection (UTI) Reagent Strips Urinary Tract Infection reagent strips positioned as the leading UTI test strip product in the US, sold through retailers and online channels for at-home consumer use.
• Foresight Allergen Test Kit Immunoblot assay that tests for 30 allergens on a single strip, sold under the Foresight brand for allergy screening.
• Promotor Molecular Diagnostics Molecular diagnostics product line including a nucleic acid extraction system and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV Genotyping, TB, and HLA-B27, targeted at clinical laboratories.
• CentriVet Animal Health Diagnostics Veterinary product line including a dual Ketone/Glucose meter and urine reagent test strips for point-of-care animal health diagnostics, sold to veterinary clinics.
• OEM Contract Manufacturing Services OEM contract manufacturing and assembly services for third-party diagnostic products, leveraging ACON's ISO13485:2016 certified and FDA-registered Hangzhou facility and Tijuana assembly plant.

Quantifiable outcome

• 100% combined sensitivity for SARS-CoV-2 IgG/IgM Rapid Test
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Major US RetailerscoreChannel Partner/ Reseller/ Distributor · 27 October 2025Flowflex Plus RSV + Flu A/B + COVID Home Test and Flowflex COVID-19 and Flu A/B Home Tests are available at most major retailers in the US through authorized distribution agreements.
• NHS UKcoreChannel Partner/ Reseller/ DistributorFlowflex COVID-19 tests have been distributed through the UK National Health Service with widespread international availability outside the US.
• Authorized US DistributorscoreChannel Partner/ Reseller/ DistributorNetwork of authorized US distributors for Flowflex COVID-19 Antigen Home Tests listed on flowflexcovid.com to prevent counterfeit product distribution.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Abbott Diagnostics: Abbott's diagnostics division (including BinaxNOW COVID and rapid antigen/lateral flow tests) directly competes with ACON's Flowflex OTC rapid antigen franchise and operates the broader POCT, immunoassay, and molecular categories where ACON's Mission and Promotor brands compete.
• Becton Dickinson (BD): BD's Veritor Plus System and rapid antigen COVID/flu tests compete with ACON's Flowflex franchise, while BD's broader medical device portfolio overlaps with ACON's POCT glucose and clinical chemistry ambitions.
• Roche Diagnostics: Roche's cobas and rapid antigen lateral flow tests, including the SARS-CoV-2 Rapid Antigen Test, compete in OTC/POCT respiratory diagnostics with ACON's Flowflex Plus products and operate in the molecular and clinical chemistry segments where ACON's Promotor brand participates.
• Siemens Healthineers: Siemens Healthineers' CLINITEST and rapid antigen COVID tests, alongside its broader POCT analyzers, are portfolio-level competitors to ACON's Mission POCT urinalysis, Mission HbA1c/lipid analyzers, and On Call MultiPro systems.
• Revvity (formerly PerkinElmer): Revvity's diagnostics business spans rapid tests, immunoassays, and molecular reagents that compete with ACON's lateral flow (Flowflex, ACON immunoassay) and Promotor molecular diagnostics lines across clinical and at-home channels.

Direct peers

• QuidelOrtho: QuidelOrtho's QuickVue and Sofia rapid antigen/influenza tests are among the closest direct competitors to ACON's Flowflex OTC COVID and Flu A/B products, and the company competes head-to-head in physician office and retail point-of-care channels.
• OraSure Technologies: OraSure's rapid at-home and point-of-care infectious disease tests (including IntelliSwab COVID-19) and its OraQuick HIV/HCV tests overlap directly with ACON's lateral flow and home-use OTC rapid test portfolio, including Flowflex and the ACON-branded immunoassays.
• Princeton BioMeditech: Princeton BioMeditech's rapid antigen COVID/flu tests and pregnancy tests (under brands such as Status and BioCard) compete directly with ACON's Flowflex, Flowflex Plus, and Distinct OTC product families in US retail and international distributor channels.

Emerging players

• Bionote: Bionote is a Korean veterinary and human rapid diagnostic manufacturer whose lateral flow tests overlap with ACON's Flowflex respiratory and CentriVet animal health portfolios, particularly in Asia-Pacific and European veterinary distribution.
• Ellume: Ellume developed and commercialized FDA-authorized OTC home COVID tests and other digital lateral flow diagnostics, positioning it as a direct emerging competitor to ACON's Flowflex in the US retail home-testing channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/acon-laboratories

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACON Laboratories